Opus Genetics (IRD) Revenue (2010 - 2026)
Opus Genetics (IRD) recorded Revenue of $755,000 in Q2 2026, down 73.8% from $2.88 million a year earlier and down 65.0% from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) Revenue (2010 - 2026) Analysis & Trends
On a TTM basis, Opus Genetics' Revenue came in at $9.86 million as of Jun 30, 2026, down 36.1% year-over-year; for FY2025, it was $14.2 million, up 29.1% from FY2024.
- Annual Revenue has a four-year compound annual growth rate of 121.6% (FY2021 to FY2025).
- Across earlier years, Revenue came in at $10.99 million in FY2024 (-42.3%), $19.05 million in FY2023 (-52.2%), $39.85 million in FY2022 and $589,000 in FY2021.
- The Q2 2026 figure is the lowest quarterly Revenue since Q3 2021.
- On a year-over-year basis, Revenue has declined for four consecutive quarters, with growth averaging 30.8% over the last eight quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 159.2% in Q2 2025, against a decline of 95.8% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.16 million (Q1 2026), $3.87 million (Q4 2025) and $3.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Opus Genetics | 417.37 Mn | 192.65 Mn | - | 755,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 755,000.00 |
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 3.87 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 2.88 Mn |
| Mar 31, 2025 | 4.37 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 11.94 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | 39.85 Mn |
| Sep 30, 2021 | 489,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2020 | 1.15 Mn |
| Jun 30, 2010 | 18,750.00 |
API Access
Opus Genetics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();